Back to Trades
Sell4
Travere Therapeutics, Inc.
TVTX
Total Value
$2.4M
Net $230.5K sold
Sales
$230.5K
1 transaction
Company Information
- Company Name
- Travere Therapeutics, Inc.
- Ticker Symbol
- TVTX
- CIK
- 0001438533
Insider Information
- Name
- REED ELIZABETH E
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Feb 3, 2026
- Transaction Date
- Jan 31, 2026
- Accession Number
- 0001283303-26-000002
- Form Type
- 4
- Net Trading Amount
- -$230.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 31, 2026 | Common Stock | 25,110 | — | Grant/Award | — |
| Feb 3, 2026 | Common Stock | 7,175 | $32.12 | Sale | $230.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 31, 2026 | Derivative | 66,960 | $33.09 | Grant/Award | $2.2M |
Footnotes
- (F1)Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer.
- (F2)Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- (F3)One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.